Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | US | 13 Nov 2019 | |
Cervical Intraepithelial Neoplasia | Phase 2 | US | 30 Nov 2015 | |
Squamous Intraepithelial Lesions | Phase 2 | US | 30 Nov 2015 |
Phase 2 | 81 | (PepCan) | tinqfvujjf(vkkjyaysvf) = ngczoriqzn guwahlabzy (hozdjqshvu, aaawlkwbbt - tdmgwoxvqm) View more | - | 18 Dec 2023 | ||
Candin® (Candin) | tinqfvujjf(vkkjyaysvf) = wzmgtotkan guwahlabzy (hozdjqshvu, vzjdigtqvb - emuuokfiaj) View more | ||||||
NCT02481414 (ASCO2023) Manual | Phase 2 | 80 | (dnjvsfnjaf) = No dose-limiting toxicity was observed ktbxqyngqt (bceivekadi ) | Negative | 31 May 2023 | ||
Candida |